1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Global Biopolar Disorder Therapeutics Market 2015-2019

Global Biopolar Disorder Therapeutics Market 2015-2019

  • December 2015
  • -
  • Infiniti Research Limited
  • -
  • 94 pages

Summary

Table of Contents

Search Inside

About bipolar disorder therapeutics
Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in for treatment. It is considered as a lifelong disease and the discontinuation of the medication can lead to relapse of the condition.

Technavio's analysts forecast the global bipolar disorder therapeutics market to grow at a CAGR of 2.24% over the period 2014-2019.

Covered in this report
The report covers the present scenario and growth prospects of the global bipolar disorder therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of bipolar disorder.

Technavio's report, Global Bipolar Disorder Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global bipolar disorder therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA


Key vendors
- Allergan
- AstraZeneca
- BMS
- Eli Lilly
- GlaxoSmithKline
- Janssen Pharmaceuticals

Other prominent vendors
- AbbVie
- Abital Pharma
- Astellas
- Convergence Pharmaceuticals
- D Pharm
- Delpor
- Gedeon Richter
- H. Lundbeck
- Intra-Cellular Therapies
- Novartis
- Noven Pharmaceuticals
- Omeros Corporation
- Otsuka
- Pfizer
- PNBDevCo
- Reviva Pharmaceuticals
- SK Biopharmaceuticals
- Sunovion Pharmaceutical

Key market driver
- Increase in prevalence of bipolar disorder
- For a full, detailed list, view our report

Key market challenge
- Use of alternative therapies
- For a full, detailed list, view our report

Key market trend
- Rise in public awareness
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Bipolar disorder (BPD)  - Market Insights, Epidemiology and Market Forecast-2023

Bipolar disorder (BPD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Bipolar disorder (BPD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Bipolar disorder (BPD) fo ...

Bipolar disorder (BPD)  - Epidemiology Forecast To 2023

Bipolar disorder (BPD)  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Bipolar disorder (BPD)  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Bipolar disorder (BPD)  in seven major markets (US, France, Germany, Italy, ...

Global Bipolar Disorder Partnering 2010-2017

Global Bipolar Disorder Partnering 2010-2017

  • $ 1495
  • Industry report
  • March 2017
  • by Currentpartnering

Summary Provides understanding and access to the bipolar disorder partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Bipolar Disorder Partnering ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.